Latest United States Startup Funding Rounds

Ferry is an AI healthcare-navigation assistant that helps patients find suitable in-network providers and schedule care. It handles the back-and-forth by checking specialty and location fit, contacting provider offices by phone and completing appointment booking by text; it reaches patients through partnerships with health systems and insurers.

Gaia Dynamics provides AI software for global trade compliance. Importers, exporters, customs brokers and consultants use it to classify goods, verify tariff and HS codes, calculate duties and monitor regulatory changes, with workflow automation intended to reduce manual review and catch compliance risks.

Distributed-energy software and battery systems that help commercial buildings lower electricity costs and maintain power during outages.

Eve Security provides runtime governance for enterprise AI agents: it discovers agents and their connections, then evaluates each action against organizational policies and allows, blocks, modifies or interrogates it before it reaches sensitive systems. Its EveGuard platform is in market with enterprise customers.

Develops an autonomous software-development platform for enterprise engineering teams.

Radian Forge manufactures large, precision metal components for naval, maritime and defense customers using robotic wire-arc additive manufacturing. Its systems deposit metal layer by layer and monitor production for traceability, enabling mission-critical parts to be made faster and closer to shipyards, depots and deployed operations than conventional casting and forging supply chains.

Delos Data builds an AI inference infrastructure platform spanning cluster software, server systems and data-interface silicon. It connects heterogeneous GPUs, accelerators, memory and storage into a resilient data domain so operators can scale inference workloads with lower latency and avoid interruptions when components or links fail.

RegCell is developing cell therapies for autoimmune disease by epigenetically reprogramming pathogenic conventional T cells into stable regulatory T cells, aiming to restore immune tolerance without gene engineering; its platform is advancing toward clinical development.

Retham is developing HITDx, a functional hospital-lab assay for heparin-induced thrombocytopenia that uses stable cryopreserved donor platelets to make clinically relevant platelet testing more practical; the diagnostic is in validation and regulatory development, while its cryopreserved platelets are available for research use.

A developer, owner and financing partner for community solar, battery storage and distributed renewable-energy projects.